ERBB2 and breast carcinoma: Moreover, although marked ethnic and race disparities in breast cancer have been observed10 and have also been inferred from the subgroup analysis in the DESTINY-Breast04 trial8, whether patients with HER2-low breast cancers may exhibit these differences is not yet clear.